Drug intelligence / Profile preview

nikethamide

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous, Sublingual
01

Overview

Nikethamide is a central nervous system and respiratory stimulant, historically classified as an analeptic. It functions by stimulating chemoreceptors in the carotid and aortic bodies, which increases the rate and depth of respiration by enhancing the sensitivity of the medullary respiratory center to carbon dioxide. While it was once widely used to treat acute respiratory depression resulting from anesthetic or sedative overdoses, its clinical utility has diminished with the advent of mechanical ventilation and more targeted antagonists. It is currently listed as a prohibited substance by the World Anti-Doping Agency (WADA) due to its potential for performance enhancement.

Brand names
CoramineCordiamin
Other names
N,N-DiethylnicotinamideNicotinic acid diethylamideNikethamidum

Beyond the preview

Go deeper on nikethamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nikethamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call